2012
DOI: 10.18632/oncotarget.805
|View full text |Cite
|
Sign up to set email alerts
|

Quantification of Mesenchymal Stem Cells (MSCs) at Sites of Human Prostate Cancer

Abstract: Circulating bone marrow-derived Mesenchymal Stem Cells (BM-MSCs) have an innate tropism for tumor tissue in response to the inflammatory microenvironment present in malignant lesions. The prostate is bombarded by numerous infectious & inflammatory insults over a lifetime. Chronic inflammation is associated with CXCL12, CCL5, and CCL2, which are highly overexpressed in prostate cancer. Among other cell types, these chemoattractant stimuli recruit BM-MSCs to the tumor. MSCs are minimally defined as plastic-adher… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
99
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 77 publications
(105 citation statements)
references
References 59 publications
5
99
0
1
Order By: Relevance
“…In this compromised (i.e., stressful) tumor microenvironment, cancer cells initiate adaptive survival pathways and activate an angiogenic switch [2]. Activation of this switch by the cancer cells recruits infiltrating host cells such as endothelial cells, myeloid- derived suppressor cells (MDSCs), macrophages, and bone marrow derived mesenchymal stem cells needed for the chronic stimulation of tumor angiogenesis and cancer cell survival signaling in such a stressful tumor microenvironment [2-6]. Such tumor angiogenesis requires HDAC4 and S100A9 dependent signaling in the cancer cells themselves as well as in the infiltrating host cells [12, 18, 26].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In this compromised (i.e., stressful) tumor microenvironment, cancer cells initiate adaptive survival pathways and activate an angiogenic switch [2]. Activation of this switch by the cancer cells recruits infiltrating host cells such as endothelial cells, myeloid- derived suppressor cells (MDSCs), macrophages, and bone marrow derived mesenchymal stem cells needed for the chronic stimulation of tumor angiogenesis and cancer cell survival signaling in such a stressful tumor microenvironment [2-6]. Such tumor angiogenesis requires HDAC4 and S100A9 dependent signaling in the cancer cells themselves as well as in the infiltrating host cells [12, 18, 26].…”
Section: Discussionmentioning
confidence: 99%
“…To continue growth in such a compromised (i.e., stressful) tumor microenvironment, cancer cells must initiate adaptive survival pathways and activate an angiogenic switch [2]. Activation of this switch recruits infiltrating host cells such as endothelial cells, myeloid- derived suppressor cells (MDSC), macrophages, and bone marrow derived mesenchymal stem cells needed for the chronic stimulation of tumor angiogenesis [2-6]. Tasquinimod (ABR-215050; PubChem CID 546828876; CAS number 254964-60-8), Figure 1A, is an orally active quinoline-3-carboxamide which produces robust and consistent in vivo growth inhibition as well as suppression of metastasis in a large series of pre-clinical human xenograft and rodent prostate cancer models [7-12].…”
Section: Introductionmentioning
confidence: 99%
“…Their physiological roles include migration into, and repair of inflammatory/injured tissues [18], and some studies aim to manipulate this property as a therapeutic intervention [19]. The intra-tumoural migratory potential of MSC however, has been difficult to assess in humans [20], but migration into tumour xenografts, following intra venous administration has been documented for prostate [21], colon [22], breast [23–24] and other murine cancers models. The presence of MSC in human cancer tissue has certainly been documented, estimating a proportion of < 1.1% of the total cells in prostate for example [21].…”
Section: Introductionmentioning
confidence: 99%
“…MSCs, a multipotent cell type capable of generating many different types of connective tissue, can also differentiate into myofibroblasts in response to secreted factors from tumors [40] . MSCs make up 1.1% of cells within the prostate cancer stroma [59] and exhibit similar tumor promoting effects to cancer associated stroma [40,60,61] .…”
Section: Activation and Modulation Of Stromal Cells By Exosomesmentioning
confidence: 99%